GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. Logo

GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

Develops and manufactures pharmaceuticals for rare diseases and unmet health needs globally.

GENIL | IS

Overview

Corporate Details

ISIN(s):
TREGENL00016 (+1 more)
LEI:
789000A4NW6W4D8Z4H25
Country:
Türkiye
Address:
MUSTAFA KEMAL MAH. 2119. SOK. NO;3 D:2-3 ÇANKAYA/ANKARA, 06520 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1998, GEN İlaç ve Sağlık Ürünleri is a pharmaceutical company focused on providing global solutions for rare diseases and unmet health needs. The company leverages over 25 years of experience through a versatile business model that includes strategic partnerships with global firms and in-house development. It operates its own GMP-certified production facility and R&D center to create and manufacture competitive products for international markets. GEN specializes in treatments within key therapeutic areas such as neurology, endocrinology, nephrology, oncology, and hematology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-21 18:22
Annual / Quarterly Financial Statement
Company General Info Form
English 12.4 KB
2025-09-30 17:10
Board/Management Information
Company General Info Form
English 2.8 KB
2025-09-30 17:10
Board/Management Information
Investor Relations Manager Resignation
Turkish 18.4 KB
2025-09-30 17:10
Environmental & Social Information
Turkish Sustainability Reporting Standards Compliant Sustainability Report
Turkish 15.9 KB
2025-09-12 14:39
Environmental & Social Information
Update About Solar Power Plant Project
Turkish 20.7 KB
2025-09-09 17:10
Transaction in Own Shares
Notification Regarding Share Buy-Back
English 7.6 KB
2025-08-28 17:19
Regulatory News Service
Disclosure of Credit Rating Score
Turkish 230.2 KB
2025-08-28 17:19
Capital/Financing Update
Disclosure of Credit Rating Score
Turkish 19.2 KB
2025-08-20 08:37
Related Party Transaction
Tender Result Notified by the Organization which Authorized by Our Company
Turkish 18.9 KB
2025-08-18 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 53.0 KB
2025-08-13 19:52
Interim Report
01.01.2025 - 30.06.2025 period activity report
Turkish 554.5 KB
2025-08-13 19:52
Interim Report
01.01.2025 - 30.06.2025 period activity report
English 2.1 MB
2025-08-13 19:52
Report Publication Announcement
01.01.2025 - 30.06.2025 period activity report
English 11.1 KB
2025-08-13 19:37
Interim Report
Financial Report
Turkish 2.3 MB
2025-08-13 19:37
Interim Report
Financial Report
English 2.6 MB

Automate Your Workflow. Get a real-time feed of all GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
MEDICOX Co., Ltd. Logo
Developing new drugs and building a distribution platform for healthcare solutions.
South Korea 054180
Medigene AG Logo
Clinical-stage immuno-oncology firm developing TCR-engineered T cell therapies for solid tumors.
Germany MDG1
MedinCell S.A. Logo
Develops long-acting injectable therapies using proprietary technology to impact global health.
France MEDCL
A CDMO for cell therapy and regenerative medicine development & manufacturing.
Japan 2370
Medios AG Logo
Compounding patient-specific therapies and supplying specialty pharma for complex conditions.
Germany ILM1
Develops cord blood stem cell therapies for osteoarthritis & infant lung disease, plus banking.
South Korea 078160
Medizen Humancare Inc Co., Ltd Logo
Offers DTC genetic testing and genomic analysis for personalized disease risk prediction.
South Korea 236340
Medy-Tox Inc. Logo
Develops and markets botulinum toxins and dermal fillers for global aesthetic & therapeutic use.
South Korea 086900
Meito  Sangyo  Co., Ltd. Logo
Produces food products and specialty chemicals for industrial and pharmaceutical applications.
Japan 2207
Merck KGaA Logo
A science & tech firm in healthcare, life science, and electronics, advancing human progress.
United States of America 6MK

Talk to a Data Expert

Have a question? We'll get back to you promptly.